DNA polymerase beta gene mutations in human bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• DNA polymerase beta (Pol β) plays a crucial role in DNA repair.
• Mutations in DNA repair genes are implicated in various cancers.
• The role of Pol β mutations in human bladder cancer remains largely unexplored.

Purpose of the Study:

• To investigate the frequency and types of mutations in the entire coding region of the human DNA polymerase beta gene in bladder cancer tissues.
• To explore potential associations between Pol β mutations and clinical/pathological features.
• To examine the relationship between Pol β mutations and alterations in known tumor suppressor genes.

Main Methods:

• Analysis of 24 human bladder cancer tissues.
• Polymerase chain reaction (PCR) amplification of the entire coding region of the DNA polymerase beta gene.
• Single-strand conformational polymorphism (SSCP) analysis.
• Direct sequence analysis.

Main Results:

• Mutations in the DNA polymerase beta gene were identified in 4 out of 24 cases (16.7%).
• The observed mutations included three missense point mutations and a single base insertion.
• The single base insertion mutation was previously identified in prostate cancer, suggesting a potential mutation hot spot.
• No significant clinical or pathological associations were found for Pol β mutations.
• Three of the four cases with Pol β mutations also exhibited alterations in p16, RB, p53, or APC genes.

Conclusions:

• DNA polymerase beta gene mutations occur in a subset of human bladder cancers.
• The identified single base insertion may represent a mutation hot spot in the DNA polymerase beta gene.
• Combined mutations in DNA polymerase beta and tumor suppressor genes might play a role in the pathogenesis of some bladder cancers.